Why Novo Nordisk Stock Flew Higher on Friday

On Friday, the stock of Novo Nordisk (NYSE: NVO) continued to be affected by results from the lab the previous day. The interesting twist: It wasn't the company conducting the research.Rather, it was the Danish pharmaceutical company's No. 1 rival. Appreciative investors bid up Novo Nordisk's stock in a mini-rally that extended into Friday; the company's share price added nearly 5% during today's session. That looked especially good next to the trajectory of the S&P 500 index, which could only manage a 0.8% increase on the day.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool